Latest News
Viking Therapeutics Holds Phase 3 Focus Despite Weekly Stock Dip
Viking Therapeutics shares declined 4.6% over the past week, yet its valuation premium over Structure Therapeutics persists, reflecting continued investor confidence in its Phase 3 obesity programs.
Chevron Gains 6% on Oil Rally, Iraq Deals Play Second Fiddle
Chevron shares advanced 6.2% last week, closely tracking a 16% jump in WTI crude oil. Non-binding agreements with Iraq were a secondary factor.
Marathon Petroleum's Market Cap Soars $8.5B on Record Refining Margins
Marathon Petroleum's market value surged $8.5 billion as refining margins hit record highs, driving shares up 10.2% to a 52-week high.
3M Stock Edges Up on Azure Deal; Q2 Earnings in Focus
3M shares gained 1.5% last week after Microsoft Azure selected its EBO connectors. Investors await Q2 earnings Tuesday, with consensus estimates of $2.27 EPS and $6.38B revenue.
Valero Hits Record High as Refining Margins Surge Ahead of Q3
Valero Energy (VLO) shares surged to a record close of $309.65, fueled by record-high U.S. refining margins and investor optimism about Q3 performance.
Annaly's High Dividend Faces Scrutiny Ahead of Earnings
Annaly Capital Management's 13% forward yield is under pressure as Q2 earnings approach, with dividend coverage razor-thin and market rates rising.
Enterprise Products Partners Delivers 6.5% Cash Return Ahead of Q2 Earnings
Enterprise Products Partners (EPD) delivers a 6.53% annualized cash-return rate, blending a 5.86% distribution yield with a projected 0.67% buyback yield, ahead of Q2 earnings.
Douglas Dynamics Rebounds on Margin Optimism
Shares of Douglas Dynamics (NYSE:PLOW) gained 3.7% last week, beating the Russell 2000 by 4.2 percentage points, as the market focuses on margin expansion prospects.
GameStop's eBay Stake Nearly Equals Its Own Market Cap
GameStop's 9.8% stake in eBay, valued at $4.86 billion, is nearly half its own market cap. A $1 change in eBay moves GME by 9.7 cents.
ImmunityBio Faces Key Warrant Expiry Test on July 24 After Friday Rebound
ImmunityBio (NASDAQ:IBRX) faces a crucial warrant expiry on July 24, with up to 6.4 million shares potentially exercised, testing trading liquidity after a Friday rebound.